The Newest in Non-Small Cell Lung Cancer (NSCLC): Emerging Therapies, Novel Approaches, Therapeutic Updates, and Barriers to Care and Incorporating Best Practice
Cost: FreeView Offer chevron_right
The Newest in Non-Small Cell Lung Cancer (NSCLC) has been designed to bring your knowledge of the rationale behind treatment of NSCLC up to date and to enhance your competence in caring for patients with NSCLC.
After viewing The Newest in Non-Small Cell Lung Cancer (NSCLC), you will be better able to:
• Describe the impact of biomarker and mutation testing and their results for the management of patients with NSCLC and apply this knowledge to patient cases.
• Describe the role and impact of the initial biopsy, including the relevance of its timing and factors affecting quality of results.
• Distinguish between different NSCLC disease subtypes on the basis of histology, biomarker, and mutation status and use the information to optimize care in the setting of patient cases.
• Discuss the ways that NSCLC has proved resistant to treatments in past and the mechanisms of action of targeted therapies, present and emerging.
Healthcare professionals specializing in: interventional radiology; nuclear medicine; oncology; palliative care; pathology; pulmonology; or those who otherwise commonly care for patients with NSCLC.